Session III:

Afib Detection and Personalized Stroke Prevention Approaches in Atrial Fibrillation

Please enter your information, and complete the following CME post test and evaluation form. Upon successful completion, your submission will be reviewed and you will receive notification shortly regarding the status of your certificate. You must achieve a minimum score of 75% to earn credit for this activity.

First Name: *

Invalid Input

Last Name: *

Invalid Input

Primary Email Address: *

Invalid Input

Confirm Your Email: *

Invalid Input

Degree: *

Invalid Input

Specialty:*

Invalid Input

Institution: *

Invalid Input

Mailing Address:*

Invalid Input

City: *

Invalid Input

State: *

Invalid Input

1) There is no evidence that supports novel oral anticoagulants providing greater benefit than aspirin in prevention of ischemic stroke outside of documented nonvalvular atrial fibrillation?

Select one*

A) True
B) False
Invalid Input Please Select one

2) EHRA/EAPCI guidelines recommend LAAC should be employed in patients with an indication for stoke prevention due to AF based upon which of the following patient characteristics?

Select one*

A) Elevated risk of bleeding
B) Patients with individual and specific risk constellation for stroke
C) Patients unwilling or unable to take oral anticoagulation
D) Contraindication to oral anticoagulation
E) All of the above
Invalid Input Please Select one

3) What are the FDA-approved stroke risk reduction methods in patients with nonvalvular atrial fibrillation?

Select one*

A) Warfarin
B) Direct oral anticoagulants
C) Left atrial appendage closure with WATCHMAN device
D) All of the above
E) None of the above
Invalid Input Please Select one

4) Aspirin is equivalent to oral anticoagulants for embolic risk reduction in nonvalvular atrial fibrillation.

Select one*

A) True
B) False
Invalid Input Please Select one

5) Which conditions constitute absolute indications for long-term warfarin as opposed to direct oral anticoagulants?

Select one*

A) Mechanical heart valve
B) Moderate-to-severe mitral stenosis in patient with atrial fibrillation
C) Antiphospholipid syndrome
D) All of the above
E) None of the above
Invalid Input Please Select one

6) In patients with nonvalvular atrial fibrillation without hypercoagulable state who are not at elevated hemorrhagic risk, long term use of a direct oral anticoagulant currently constitutes the first line embolic prevention method.

Select one*

A) True
B) False
Invalid Input Please Select one

7) Which statement below is FALSE regarding the currently available direct oral anticoagulants (DOAC) in patients with nonvalvular atrial fibrillation at low baseline hemorrhage risk?

Select one*

A) Apixaban proved to have an overall good safety/efficacy profile in 2 randomized controlled trials against aspirin and warfarin
B) Rivaroxaban is the DOAC best studied in high embolic risk patients, that showed a good safety/efficacy profile
C) Dabigatran was studied in a double blind randomized controlled trial against warfarin
D) Direct oral anticoagulants have never been compared head-to-head in a randomized trial for efficacy/safety
Invalid Input Please Select one

8) Based on the current guidelines for nonvalvular atrial fibrillation management, which statement concerning shared decision making is FALSE?

Select one*

A) Selection of stroke prevention measure should be individualized on the basis of shared decision-making after discussion of the absolute risks and relative risks of ischemic & hemorrhagic stroke and bleeding
B) Reevaluation of the need for & choice of stroke prevention measure at periodic intervals is recommended to reassess stroke and bleeding risks
C) Left atrial appendage closure may be considered in patients at increased risk of stroke who have contraindications to long-term anticoagulation
D) Patients should be pressured to use the prevention method that their physicians see fit
Invalid Input Please Select one

9) Patients with AF when compared to non-AF patients, have shown which characteristics as it relates to myocardium extensions?

Select one*

A) More common
B) More discontinuities
C) More myocyte hypertrophy
D) More fibrosis
E) All of the above
Invalid Input

10) In patients with CHF, and AF, catheter ablation achieves which of the following outcomes?

Select one*

A) Improves survival
B) Reduces hospitalization
C) Improves symptoms
D) Decreases the rate of stroke and is associated with low complications
E) All of the above
Invalid Input

Although optional, we respectfully request that you complete the activity evaluation form, since your feedback assists in the development of future educational activities.

Background

Please rate each question using a scale of 1 to 5 (1 = Beginner, 5 = Advanced)

I would consider my level of expertise in the subject matter prior to the webcast as:

12345Invalid Input Please Select one

I would consider my level of expertise in the subject matter after the activity

12345Invalid Input

Considering my experience and background, the material presented was:

12345Invalid Input Please Select one

Extent to which activity met the identified objectives
Please rate each question using a scale of 1 to 5 (1 = Not Met, 5 = Completely Met)

Review the safety and efficacy of left atrial appendage closure for stroke prevention in NVAF.

12345Invalid Input Please Select one

Discuss the efficacy of lifelong antithrombotic therapy for NVAF.

12345Invalid Input Please Select one

Assess AFib ablation and emerging approaches for stroke presentation in AF.

12345Invalid Input Please Select one

Information Presented
Please evaluate the information that was presented by answering Yes, No, Maybe or Not Applicable

Reinforced my current practice/treatment habits: